Early research (Phase 1)WithdrawnNCT00800566What this trial is testingOral Clofarabine in Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemiaChronic Lymphocytic Leukemia M.D. Anderson Cancer Center
Early research (Phase 1)Study completedNCT00005967What this trial is testingTipifarnib in Treating Patients With Advanced Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more National Cancer Institute (NCI) 36
Early research (Phase 1)Looking for participantsNCT06528301What this trial is testingUB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell MalignanciesWho this might be right forLymphoma, B-CellLymphoma, Non-Hodgkin (NHL)Lymphoma, Large B-Cell, Diffuse (DLBCL)+1 more Umoja Biopharma 106
Early research (Phase 1)Study completedNCT01120457What this trial is testingFirst in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell CancersWho this might be right forAcute Myelogenous LeukemiaDiffuse Large B-Cell LeukemiaChronic Lymphocytic Leukemia+1 more Bristol-Myers Squibb 96
Large-scale testing (Phase 3)Study completedNCT02756611What this trial is testingEvaluate the Efficacy of Venetoclax Monotherapy in Relapsed/Refractory Participants With Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia AbbVie 258